Bicycle Therapeutics
BCYC
39 hedge funds and large institutions have $341M invested in Bicycle Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 4 closing their positions.
3,731% more capital inflows, than outflows
Capital inflows: $109M | Capital outflows: $2.84M
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
44% more funds holding
Funds holding: 27 → 39 (+12)
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
13.92% more ownership
Funds ownership: 24.93% → 38.85% (+14%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$43.7M |
| 2 |
Logos Global Management
San Francisco,
California
|
+$20.6M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$13.5M |
| 4 |
Eventide Asset Management
Boston,
Massachusetts
|
+$10.6M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$5.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$521K |
| 3 |
Two Sigma Investments
New York
|
-$366K |
| 4 |
Millennium Management
New York
|
-$259K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$167K |
BCYC Hedge Fund Activity: Q1 2021 in Review
39 of the 5,714 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q1 2021, worth a combined $341M — up 159% from $132M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new BCYC positions and 4 closed out — a net gain of 12 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $43.7M. The largest seller was Renaissance Technologies, cutting an estimated $1.4M.
- 39 institutional investors held Bicycle Therapeutics (BCYC) as of Q1 2021, up from 27 in Q4 2020.
- Funds reported $341M of Bicycle Therapeutics stock for Q1 2021, up 159% quarter-over-quarter.
- 16 funds opened new Bicycle Therapeutics positions in Q1 2021 and 4 closed out, a net change of +12 holders.
- The largest Bicycle Therapeutics buyer in Q1 2021 was Janus Henderson Group, an estimated $43.7M added.
- The largest Bicycle Therapeutics seller in Q1 2021 was Renaissance Technologies, an estimated $1.4M sold.
Based on aggregated 13F filings for Q1 2021.